GRCL
Gracell Biotechnologies Inc.
485.20$
-2.8%
vs. previous close
Closing price · As of: Aug 13, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| – | – | – | -83,210.4% | – | – | |
| – | – | – | 16,466.4% | – | – | |
| – | – | – | 16,498.4% | – | – | |
| – | – | – | 16,852.7% | – | – | |
| – | – | – | 6,900.5% | – | – | |
| – | – | – | 15,503.6% | – | – | |
| – | – | – | -11,370.5% | – | – | |
| – | – | – | 0.0% | – | – | |
| – | – | – | 5,447.8% | – | – | |
| – | – | – | 397,864.8% | – | – | |
| – | – | – | 293,633.3% | – | – | |
| – | – | – | -98,713.9% | – | – |
Data as of: August 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.